Publicaciones en colaboración con investigadores/as de Hospital Ruber Internacional (68)

2024

  1. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

2023

  1. Esophageal biomechanics assessed by impedance planimetry (EndoFLIPTM) in healthy subjects and in patients with eosinophilic esophagitis. Normality values

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 12, pp. 693-699

  2. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  3. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  4. Primary percutaneous coronary intervention in centenarians: Time to be ready

    Revista Espanola de Geriatria y Gerontologia, Vol. 58, Núm. 1, pp. 46-48

  5. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

  6. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Corticospinal tract and motor cortex degeneration in pure hereditary spastic paraparesis type 4 (SPG4)

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 1-2, pp. 25-34

  2. Tract-specific damage at spinal cord level in pure hereditary spastic paraplegia type 4: a diffusion tensor imaging study

    Journal of Neurology, Vol. 269, Núm. 6, pp. 3189-3203

2021

  1. Epidaily, a scale for comprehensive functional assessment of patients with epilepsy

    Epilepsy and Behavior, Vol. 114

  2. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  3. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  4. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  5. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  6. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

    Journal of the Neurological Sciences, Vol. 423

  7. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428

  8. Post-covid syndrome: A reflection and opinion paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279

  9. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  10. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  11. Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life

    Parkinson's Disease, Vol. 2021